As shown in Figure 3, the growth of DLBCL cells was increasingly inhibited with increasing days of treatment with combined tk-VLPs and GCV, reaching an inhibition rate of 60% after 5 days of treatment relative to the control treatment with PBS. This evidence concerns the gene TKT and diffuse large B-cell lymphoma.